SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-046024
Filing Date
2022-04-14
Accepted
2022-04-14 16:15:10
Documents
5
Period of Report
2022-05-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm227626d1_def14a.htm DEF 14A 368829
2 GRAPHIC image_001.jpg GRAPHIC 5451
3 GRAPHIC tm227626d1_def14aimg001.jpg GRAPHIC 1756
4 GRAPHIC tm227626d1_def14img002.jpg GRAPHIC 110832
5 GRAPHIC tm227626d1_def14img003.jpg GRAPHIC 101896
  Complete submission text file 0001104659-22-046024.txt   673406
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

IRS No.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39231 | Film No.: 22827419
SIC: 2836 Biological Products, (No Diagnostic Substances)